Category: Stock Market

  • 4 reasons to buy this ASX 300 tech share today

    excited woman looking at ASX share price on computer screen

    S&P/ASX 300 Index (ASX: XKO) tech share Tyro Payments Ltd (ASX: TYR) is marching higher today.

    Shares in the payments company closed yesterday trading for $1.005. In late morning trade on Wednesday, shares are changing hands for 1.012 apiece, up 0.7%.

    For some context, the ASX 300 is just about flat at this same time.

    Today’s outperformance is par for the course this year, with the Tyro share price up 21.2% in 2025, racing ahead of the 4.9% year-to-date gains posted by the benchmark index.

    And looking ahead, Family Financial Solutions’ Jabin Hallihan expects more outperformance from the ASX 300 tech share (courtesy of The Bull).

    Here’s why.

    Should you buy Tyro Payments shares today?

    “Tyro provides electronic payment solutions and banking services to Australian businesses,” Hallihan said.

    Citing the first reason he has a buy recommendation on the ASX 300 tech share, he said, “The company reaffirmed fiscal 2026 guidance for normalised gross profit of between $230 million and $240 million and an EBITDA margin of between 28.5% and 30%.”

    As for the second reason, Hallihan noted, “Tyro is launching a new banking platform to boost merchant adoption.”

    And the company has strong growth potential.

    “Tyro’s modern technology and strong performance support growth,” Hallihan said.

    And the fourth reason is that Tyro shares are trading more than 28% below Family Financial’s fair value estimate.

    “Shares remain below our fair value estimate of $1.30, so we recommend accumulating the stock. The shares were trading at $1.037 on December 4,” Hallihan concluded.

    What’s the latest from the ASX 300 tech share?

    Tyro Payments shares closed up 2% on 26 November, the day the company held its annual general meeting (AGM).

    “We have made good progress against our strategic initiatives and in making Tyro a more profitable business,” Tyro CEO Jon Davey said on the day.

    Davey added:

    In FY25, we increased our gross profit to $220.1 million, representing growth of 4.4% and we improved our EBITDA margin to 28.0%.

    Today we are reaffirming our FY26 guidance, which is to generate between $230 million and $240 million of gross profit and an EBITDA margin of between 28.5% and 30%.

    Looking to the growth opportunities for the ASX 300 tech share, Tyro chair Fiona Pak-Poy said, “We are exploring opportunities across three categories.”

    She continued:

    The first is building greater payments scale, as the transaction with SmartPay offered.

    The second is acquiring payments capabilities or software in support of our omnichannel offering, much like Medipass has done for Tyro Health.

    The third category is banking, and we will explore opportunities to grow our banking book where there is strong payments overlap.

    The post 4 reasons to buy this ASX 300 tech share today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Tyro Payments Limited right now?

    Before you buy Tyro Payments Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Tyro Payments Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Tyro Payments. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why 4DMedical, Megaport, Meteoric Resources, and Ramelius shares are racing higher today

    A young woman drinking coffee in a cafe smiles as she checks her phone.

    The S&P/ASX 200 Index (ASX: XJO) is on course to record another small decline. In afternoon trade, the benchmark index is down 0.1% to 8,575.2 points.

    Four ASX shares that are not letting that hold them back are listed below. Here’s why they are rising:

    4DMedical Ltd (ASX: 4DX)

    The 4DMedical share price is up 4.5% to $2.15. Investors have been buying the respiratory imaging technology company’s shares after it entered into a commercial agreement with the University of Miami. This has seen the leading academic medical centre commence clinical use of 4DMedical’s CT:VQ product under a structured launch framework. The CT:VQ solution is designed to set new benchmarks in cardiothoracic imaging by combining ventilation and perfusion analysis. 4DMedical’s CEO and founder, Andreas Fouras, said: “I am very pleased to see CT:VQ deployed at the University of Miami. The immediate transition from strong RSNA engagement to commercial operations demonstrates the significant momentum we are seeing from clinicians seeking a contrast-free, high-resolution alternative to nuclear medicine VQ scans.”

    Megaport Ltd (ASX: MP1)

    The Megaport share price is up 1.5% to $13.50. This may have been driven by a broker note out of Macquarie Group Ltd (ASX: MQG). This morning, the broker retained its outperform rating with an improved price target of $21.70. It said: “Top line is stabilised, Latitude adds a new growth driver in a fast-growing end market. Reinvestment in growth will drive further top-line acceleration out of FY26. Product roadmap suggests MP1 will move more into software with edge compute, driving higher long-term margins. Retain Outperform.”

    Meteoric Resources NL (ASX: MEI)

    The Meteoric Resources share price is up 4.5% to 15.7 cents. This follows news that the rare earths developer has produced its first batch of mixed rare earth carbonate (MREC) from its recently constructed pilot plant for the Caldeira Rare Earth Project in Brazil. Meteoric Resources’ managing director, Stuart Gale, said: “It’s great to deliver our first batch of MREC from the Caldeira Project. The team have done an excellent job in the development of the Pilot Plant – from acquisition of key equipment, recruitment of operators, construction and commissioning. This now places Meteoric in a small group of global companies with the ability to independently and consistently produce MREC product.”

    Ramelius Resources Ltd (ASX: RMS)

    The Ramelius Resources share price is up 6% to $3.59. This morning, this gold miner revealed that it plans to undertake a $250 million share buyback. Ramelius’ managing director, Mark Zeptner, said: “At the time of the release of our 5-Year Growth Pathway to 500koz, the Ramelius Board gave clear direction to management that we need to “maintain and grow” shareholder returns. We are demonstrating this today in the form of a A$250 million share buyback program and an increase in the minimum dividend payable.”

    The post Why 4DMedical, Megaport, Meteoric Resources, and Ramelius shares are racing higher today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in 4DMedical Limited right now?

    Before you buy 4DMedical Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and 4DMedical Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Megaport. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Megaport. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why Cogstate, European Lithium, GQG Partners, and Lindian Resources shares are falling today

    Frustrated and shocked business woman reading bad news online from phone.

    In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on track to record a small decline. At the time of writing, the benchmark index is down 0.25% to 8,565.4 points.

    Four ASX shares that are falling more than most today are listed below. Here’s why they are dropping:

    Cogstate Ltd (ASX: CGS)

    The Cogstate share price is down 19% to $2.03. Investors have been selling the neuroscience technology company’s shares following the release of a disappointing business update. Due to timing-related deferrals, Cogstate expects first half total revenue to be in the range of $25 million to $26 million. This is an increase of only 5% to 9% on the prior corresponding period, which is short of its previous guidance for between 18% and 20% revenue growth. And with management expecting costs to increase and put pressure on margins, its earnings will also be well short of what the market was forecasting.

    European Lithium Ltd (ASX: EUR)

    The European Lithium share price is down 5% to 18 cents. This morning, this critical metals company revealed that a term sheet has been executed for a 50%-50% joint venture between Critical Metals Corp (NASDAQ: CRML) and Fabrica de Prelucrare a Concentratelor de Uraniu of Romania. The latter is a state-owned entity and strategic partner. European Lithium owns approximately 45% of Critical Metals Corp. Its flagship Tanbreez project is one of the world’s largest, rare earths deposits and is located in Southern Greenland. Broad weakness in the rare earths industry today appears to be overshadowing this.

    GQG Partners Inc (ASX: GQG)

    The GQG Partners share price is down 2.5% to $1.73. This follows the release of the fund manager’s latest funds under management (FUM) update this morning. According to the release, GQG Partners’ FUM grew approximately 1.5% to US$166.1 billion during the month of November. While this is positive, the FUM growth was all performance related, with the company continuing to experience outflows. The company recorded a total monthly fund outflow of US$2.4 billion for November, with weakness across all four segments.

    Lindian Resources Ltd (ASX: LIN)

    The Lindian Resources share price is down almost 5% to 36.2 cents. This is despite the rare earths company announcing that it has completed the final US$10 million tranche payment for the acquisition of Rift Valley Resource Developments Limited. It is the Malawian company that holds 100% ownership of the Kangankunde Rare Earths Project. The company’s executive chair, Robert Martin, commented: “Achieving 100% ownership of Kangankunde marks another important milestone in Lindian’s journey. This structure provides clear alignment of our operational entities under which recent contracts have been secure, and with Stage 1 construction advancing rapidly and Stage 2 studies well underway, this consolidation provides full strategic and operational control as we move toward first production on what is one of the rare earth industry’s most significant development projects.”

    The post Why Cogstate, European Lithium, GQG Partners, and Lindian Resources shares are falling today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CogState Limited right now?

    Before you buy CogState Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CogState Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has positions in Gqg Partners. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cogstate. The Motley Fool Australia has positions in and has recommended Cogstate. The Motley Fool Australia has recommended Gqg Partners. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Down 20% since November, are Bendigo Bank shares now a buy?

    Happy young woman saving money in a piggy bank.

    Bendigo and Adelaide Bank Ltd (ASX: BEN) shares are slipping today.

    Shares in the S&P/ASX 200 Index (ASX: XJO) bank stock closed yesterday trading for $10.37. In late morning trade on Wednesday, shares are swapping hands for $10.34 apiece, down 0.3%.

    For some context, the ASX 200 is up 0.1% at this same time.

    Taking a step back, Bendigo Bank shares are down 22.3% over 12 months, trailing the 2.4% one-year gains posted by the benchmark index. Though that doesn’t include the two fully-franked dividends totalling 63 cents a share the bank paid out over the year.

    At the current price, Bendigo Bank stock trades on a fully franked trailing dividend yield of 6.1%.

    Which brings us back to our headline question.

    With the ASX 200 bank stock down 20.1% since early November, is it time to buy the dip?

    Bendigo Bank shares: Buy, hold, or sell?

    Family Financial Solutions’ Jabin Hallihan recently ran his slide rule over the Aussie bank (courtesy of The Bull).

    “Bendigo and Adelaide Bank is one of Australia’s largest regional banks,” Hallihan said.

    Commenting on the big fall Bendigo Bank shares suffered in November, he noted, “Recently, an independent report highlighted weaknesses in the bank’s anti-money laundering and counter terrorism financing controls. The shares plunged on the news.”

    Despite that regulatory weakness, Hallihan has a hold recommendation on the stock. He said:

    The bank is committed to undertaking the necessary enhancements to systems, frameworks and processes to ensure full compliance with its obligations under the Anti-Money Laundering and Counter Terrorism Financing Act 2006.

    Hallihan concluded, “The shares on December 4 were trading below our $11 target. We suggest holding the stock, but investors should monitor regulatory developments and the bank’s remediation plan.”

    What happened with the ASX 200 bank stock in November?

    Bendigo Bank shares had two horror days of trading last month.

    On 11 November, shares in the ASX 200 bank stock closed down 8.5% following the release of the company’s first-quarter (Q1 FY 2026) results, which fell short of market expectations.

    Two weeks later, on 25 November, shares tumbled another 7.4% after the bank reported on an independent Deloitte review. That review identified deficiencies in Bendigo Bank’s approach to identifying, mitigating, and managing money laundering and terrorism financing risk between 1 August 2019 and 1 August 2025 at multiple branches.

    The Bendigo Bank board said it is committed to fully funding the uplift program to address all of the identified deficiencies.

    The post Down 20% since November, are Bendigo Bank shares now a buy? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Bendigo and Adelaide Bank Limited right now?

    Before you buy Bendigo and Adelaide Bank Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Bendigo and Adelaide Bank Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Bendigo And Adelaide Bank. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why is this ASX All Ords share crashing 30% today?

    A man slumps crankily over his morning coffee as it pours with rain outside.

    The market may be edging higher today, but the same cannot be said for the ASX All Ords share in this article.

    In morning trade, investors have sold this share down by as much as 30% to $1.75.

    Which ASX All Ords share?

    The share that is crashing down to earth on Wednesday is Cogstate Ltd (ASX: CGS).

    It is a neuroscience technology company aiming to optimise brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare.

    The company highlights that its technologies provide rapid, reliable, and highly sensitive computerised cognitive tests across a growing list of domains. These support partners in the delivery of electronic clinical outcome assessment (eCOA) solutions that replace costly and error-prone paper assessments with real-time data capture.

    Why is it crashing?

    Investors have been selling down the ASX All Ords share following the release of a disappointing business update.

    According to the release, timing-related deferrals are expected to have a short-term impact on reported revenue and profitability in the first half of FY 2026.

    It notes that Clinical Trial sales contracts are progressing well and it expects to execute sales contracts of approximately $37 million to $40 million during the first half. This represents 82% to 97% growth on the prior corresponding period. It will also be the company’s second-best half-year result for contracts executed.

    This performance is being supported by a record level of pipeline opportunities and ongoing conversion of those opportunities into contracted work.

    However, timing delays are expected to impact revenue recognition in the half. This is primarily due to contracts signed late in the December quarter, which provide limited time for revenue to be recognised within the period.

    Additionally, management notes that the mix of revenue is a contributing factor. Upfront license fees will represent a smaller share of revenue, with license revenue expected to be approximately 19% to 20% of total revenue in the first half. This is consistent with the 19% recorded in the prior corresponding period, but down from 31% in the second half of FY 2025.

    As a result, total revenue for the first half of FY 2026 is now forecast to be in the range of $25 million to $26 million. This is an increase of approximately 5% to 9% on the prior corresponding period. Disappointingly, it falls short of its previous guidance for between 18% to 20% revenue growth.

    Making things worse is that management expects its costs to be higher during the half, putting pressure on its margins. For example, its EBIT margin is expected to be 14% to 17.5%, compared to 28% during the second half of FY 2025.

    Cogstate’s CEO, Brad O’Connor, commented:

    Cogstate’s future has never looked brighter. We are seeing a record level of opportunities from an expanded customer base and across more indications, and those opportunities are now translating into higher levels of sales contracts.

    The expected value of sales contracts to be executed in this December half is the second-highest half-year result in the company’s history and is a higher quality outcome because of the diversity of contracts. Our best half-year for contract sales was the December 2021 half, when we executed $54.5 million of sales contracts, with more than $30 million attributable to a single large trial. In contrast, the largest contract executed in the current half is just over $6 million.

    The post Why is this ASX All Ords share crashing 30% today? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CogState Limited right now?

    Before you buy CogState Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CogState Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cogstate. The Motley Fool Australia has positions in and has recommended Cogstate. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 1 magnificent ASX dividend share down 19% to buy and hold for decades

    Man holding out Australian dollar notes, symbolising dividends.

    ASX dividend shares have always been a favourite among Aussies seeking a steady passive income from reliable, well-established companies. By holding onto a quality stock for a long period of time, investors can benefit from the power of compounding and long-term business growth.

    There are many ASX dividend shares out there which can offer this type of income. But there is one in particular which I think offers a fantastic buying opportunity right now: Sonic Healthcare Ltd (ASX: SHL).

    Sonic Healthcare shares are trading in the red on Wednesday morning. At the time of writing, the shares are down 0.9% to $23 a piece.

    Over the past month, the shares have climbed 8.9%. But after a steep sell-off following the company’s FY25 results announcement in August, the share price is 19.13% lower than this time last year.

    Why are Sonic Healthcare shares a great ASX dividend buy today?

    The ASX dividend stock is the seventh largest healthcare share on the ASX 200 Index, by market capitalisation. The company is a global leader in pathology and diagnostic imaging, operating across Australia, Europe, and the United States.

    The business is well diversified and in a good position to benefit from long-term tailwinds amid an ageing population. 

    As a diagnostics healthcare company, demand for Sonic Healthcare’s services are expected to boom in coming decades as older individuals have more need for regular and repeated pathology tests to help with any upcoming chronic illnesses. 

    At the same time, there is also growing awareness among other age groups about the benefits of early disease detection and preventive health screening.

    When it comes to its dividends, Sonic Healthcare offers an attractive yield. In FY25, the company declared it would pay a full-year dividend of $1.07 per share to investors. 

    And after a tough period, the market is expecting the company’s dividends to grow steadily over the next few years.

    Bell Potter forecasts dividends of $1.09 per share in FY26 and $1.11 in FY27. The consensus estimate is for a dividend yield of 4.6% in FY26.

    Where do analysts think the share price will go next?

    Analysts at Bell Potter have said they think the ASX dividend company is ready for a return to consistent growth. They also said investors should be snapping up the shares.

    The broker has a buy rating and $33.30 target price on the shares. At the time of writing, this implies a 44.8% upside for investors over the next 12 months. 

    Macquarie is a little less bullish on the shares. The broker has a buy rating and 12-month target price of $25.20 on the stock, although this still implies a potential 9.6% upside ahead.

    The post 1 magnificent ASX dividend share down 19% to buy and hold for decades appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Sonic Healthcare Limited right now?

    Before you buy Sonic Healthcare Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sonic Healthcare Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Alphabet stock jumped 13.9% in November. What’s next?

    Woman and man calculating a dividend yield.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Key Points

    • Alphabet surged nearly 14% in November while the Nasdaq declined, bucking a broader tech sell-off driven by AI bubble fears.
    • Google’s Gemini 3, trained on the company’s own chips, validated its long-term bet on custom silicon.

    While much of tech saw red in November, it was a strong month for Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), with shares of the Google parent rising 13.9% from the closing bell on Oct. 31 to the end of November’s trading. The S&P 500 ticked up 0.1% over the same period, though it had dropped as much as 4.4% mid-month, while the tech-heavy Nasdaq Composite finished down 1.5%, having fallen as much as 6.9%. 

    Fears of an artificial intelligence (AI) bubble weighed on much of the market, but Alphabet was able to shrug them off because, in large part, the company helped ignite this latest iteration of AI bubble talk in the first place.

    Gemini 3 proves Google can compete without Nvidia’s chips

    Google’s release of Gemini 3, its latest AI model, directly challenged Nvidia and OpenAI’s place at the heart of the AI boom. Gemini 3 was not only received as a significant improvement on the latest models from its competitors, but critically, it was trained not with Nvidia’s chips, but Google’s.

    These chips — called TPUs — are specifically designed and optimized for the kinds of operations that Google uses to train its models, making them both cheaper to produce and cheaper to run. This was a big moment for the industry, which had been largely operating under the assumption that in order to produce the best AI models, you needed Nvidia’s latest GPUs. 

    Gemini 3’s obvious quality is a wake-up call for Nvidia and other semiconductor companies. If Google continues down this path and other hyperscalers follow, Nvidia’s pricing power could be in danger.

    It’s also a major win for Alphabet, validating Google’s long-term bet on custom silicon.

    Google must renegotiate its search contracts every year

    December hasn’t been as kind to Alphabet shares, which are down slightly in the first days of the month. On Friday, a judge ordered Google to limit its default search contracts to a maximum of one year as part of an earlier ruling that the company had built a search and advertising monopoly. The company must now renegotiate its search contracts each year, including a critical deal with Apple, which makes it the go-to iPhone search engine.

    I think that Alphabet is one of the best picks among big tech. If AI delivers on its promise, Alphabet will reap the rewards. If it doesn’t, Alphabet’s stock will undoubtedly get hit, but its core business will remain incredibly strong, and shares will recover.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    The post Alphabet stock jumped 13.9% in November. What’s next? appeared first on The Motley Fool Australia.

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    Should you invest $1,000 in Alphabet right now?

    Before you buy Alphabet shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Alphabet wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p { margin-bottom: 0 !important; }

    This article was originally published on Fool.com. All figures quoted in US dollars unless otherwise stated.

    More reading

    Johnny Rice has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Alphabet, Apple, and Nvidia. The Motley Fool Australia has recommended Alphabet, Apple, and Nvidia. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Rare earths company ticks off key production milestone

    Image of young successful engineer, with blueprints, notepad and digital tablet, observing the project implementation on construction site and in mine.

    Shares in Meteoric Resources Ltd (ASX: MEI) were trading higher on Wednesday after the company announced it had produced its first batch of rare earths from its recently-constructed pilot plant in Brazil.

    The company said in a statement to the ASX that commissioning of the plant started with the introduction of low-grade clay ore into the plant over a two-week period.

    Several technical processes were then carried out, the company said.

    As it told the ASX:

    The pilot plant further validates and optimises the flowsheet and tests different ore types from the Caldeira Project. Data generated from the pilot campaigns will be incorporated into the Caldeira Project definitive feasibility study (DFS) currently being undertaken by Ausenco.

    New ores to be tested

    Having been tested using low-grade ore, the pilot plant would now move on to ores with grades more typical of the company’s Brazilian deposit.

    Technical imporvements could also be made, the company said.

    The pilot plant also provides an opportunity to pilot the separation of rare earths by solvent extraction and other technologies such as flash joule heating (FJH). During the commissioning and early operation several opportunities have already been realised which will be reflected in the definitive feasibility study which is currently in progress.  

    Meteoric Resources Managing Director Stuart Gale said it was a key milestone for the company.

    It’s great to deliver our first batch of mixed rare earth carbonate (MREC) from the Caldeira Project. The team have done an excellent job in the development of the pilot plant – from acquisition of key equipment, recruitment of operators, construction and commissioning. This now places Meteoric in a small group of global companies with the ability to independently and consistently produce MREC product.

    Mr Gale said the pilot plant’s design was based on extensive test work conducted at Australian government agency ANSTO, “including four continuous pilot runs of five days each”.

    This foundation allows the pilot plant to expand upon the results achieved at ANSTO and simultaneously facilitate the training of plant operators. The pilot plant enables ongoing refinement of key project parameters and process optimisation, strengthening our understanding of the Caldeira Project. Combined with our expanding geological intellectual property, this pilot plant establishes a strong foundation for enhancing long-term project value.

    Meteoric Resources shares were trading 3.3% higher at 15.5 cents on the news on Wednesday.

    Macquarie has a 12-month price target of 39 cents on Meteoric Resources shares, saying its progress on the pilot plant “will enable the company to start off-take discussions with downstream customers, a key near-term catalyst”.

    The post Rare earths company ticks off key production milestone appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Meteoric Resources NL right now?

    Before you buy Meteoric Resources NL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Meteoric Resources NL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Charter Hall Group unveils 42.28c per security capital reallocation

    A woman sits at her computer with her chin resting on her hand as she contemplates her next potential investment.

    The Charter Hall Group (ASX: CHC) share price is in focus after the company announced a capital reallocation of 42.28 cents per security, following securityholder approval at its November AGM. Key features include a return of capital and a special fully franked dividend, with no cash changing hands for investors.

    What did Charter Hall Group report?

    • Capital reallocation of 42.28 cents per stapled security approved and set for 18 December 2025
    • Return of capital of 11.61 cents per Charter Hall Limited (CHL) share
    • Special fully franked dividend of 30.67 cents per CHL share (franking credit: 13.14 cents)
    • No cash payment or issue/cancellation of securities for securityholders
    • ATO draft class ruling obtained; formal ruling expected within six weeks

    What else do investors need to know?

    Securityholders will not receive any cash from the capital reallocation. Instead, the capital will shift from Charter Hall Limited to Charter Hall Property Trust, automatically adjusting the cost base for each security. This may have future tax implications for investors.

    The capital reallocation is scheduled for 18 December 2025, with the record date on 17 December 2025. Confirmation letters and statements will be sent out to investors on or about 9 January 2026.

    What’s next for Charter Hall Group?

    Charter Hall expects the capital reallocation to support the group’s ongoing capital management strategy, enhancing transparency and cost base alignment for investors. The company awaits the final ATO class ruling to confirm the tax treatment for securityholders.

    Management says key documents, including the AGM Notice, Explanatory Memorandum, and tax ruling, will be available on the company’s website to support investor understanding.

    Charter Hall Group share price snapshot

    Over the past 12 months, Charter Hall Group shares have climbed 67%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen around 2% over the same period.

    View Original Announcement

    The post Charter Hall Group unveils 42.28c per security capital reallocation appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Charter Hall Group right now?

    Before you buy Charter Hall Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Charter Hall Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Up 106% in 2025, ASX All Ords gold stock lifting today on 1.2-million-ounce reserve boost

    Man in mining hat with fists raised and eyes closed looking happy and excited about the Newcrest share price

    ASX All Ords gold stock Strickland Metals Ltd (ASX: STK) is marching higher today.

    Strickland Metals shares closed yesterday trading for 18 cents apiece. In morning trade on Wednesday, shares are changing hands for 18.5 cents apiece, up 2.8%.

    For some context, the All Ordinaries Index (ASX: XAO) is also just about flat at this same time.

    With today’s intraday gains factored in, the Strickland Metals share price is up 105.6% in 2025.

    Here’s what’s happening with the ASX gold miner.

    ASX All Ords gold stock announces 1.2-million-ounce MRE

    Stickland Metals shares are in the green today after the ASX All Ords gold stock announced a maiden Mineral Resource Estimate (MRE) for the Gradina Deposit. Gradina sits within Stickland’s 100%-owned Rogozna Gold and Base Metals Project, located in Serbia.

    The maiden MRE came in at 12 million tonnes at 3 grams of gold per tonne (12Mt at 3g/t Au). That equates to 1.2 million ounces of gold. And it lifts the total inferred MRE at the Rogozna Project by 16% to 8.6 million ounces of gold equivalent (AuEq).

    The miner highlighted that the discovery cost was only US$10 per ounce.

    And the ASX All Ords gold stock noted that the mineralisation remains open in all directions, with “significant near-term growth potential” in a number of adjacent areas where it will conduct further exploratory drilling in 2026.

    Drilling is ongoing at the Rogozna Project, with two rigs drilling the so-called Gradina “gap zone”, while three rigs are focused on discovery drilling across the broader project area.

    Strickland said it is well-funded to support the ongoing drilling campaign, reporting cash and liquids of $41.8 million as at 30 September.

    What did management say?

    Commenting on the maiden resource estimate that’s helping boost the ASX All Ords gold stock today, Strickland managing director Paul L’Herpiniere, said, “Delivering a maiden resource of 1.2Moz Au for the Gradina Deposit, with an average grade of 3.0g/t Au, is an outstanding result which reinforces the quality and scale of the Rogozna Project.”

    L’Herpiniere added:

    Recent drilling at Gradina has delivered some exceptional intercepts of high-grade, gold-dominant mineralisation across the length of the deposit, underpinning a substantial maiden MRE at a discovery cost of just $US10/oz. By global standards, this is a very high return on exploration investment, highlighting the value that Rogozna’s large-scale mineralisation style offers.

    Looking ahead, L’Herpiniere said, “This latest update follows the substantial MRE updates posted earlier this year and sets the scene for continued growth into 2026, with an updated MRE for the cornerstone Shanac Deposit due in early 2026.”

    The post Up 106% in 2025, ASX All Ords gold stock lifting today on 1.2-million-ounce reserve boost appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Strickland Metals Ltd right now?

    Before you buy Strickland Metals Ltd shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Strickland Metals Ltd wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 18 November 2025

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.